Dilpacimab
Product Specifications
CAS Number
1791420-09-1
Target
VEGFR, Gamma-secretase
Related Pathways
Angiogenesis, Stem Cells, Neuroscience, Proteases/Proteasome, Tyrosine Kinase/Adaptors
Purity
0.977
Bioactivity
Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin that simultaneously targets the delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) signaling pathways. Dilpacimab has significant potential in cancer research due to its dual targeting of tumor angiogenesis and Notch signaling.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A12319-1-Cy3 100 µg/Vial
Anti-TMED5/p28 Antibody Picoband®, Cy3 Conjugate
Sign In for Pricing
View Details G8602-75C 100 µL
LGR7 (Relaxin Receptor 1, Leucine-rich Repeat-containing G-protein Coupled Receptor 7, Relaxin Family Peptide Receptor 1, RXFP1) (Not for Export EU)
Sign In for Pricing
View Details 